HOME PRACTICE AREAS ABOUT US CONTACT US STATE RESOURCES CASE REVIEW
  VIDEO LIBRARY   TODAY'S LEGAL HEADLINES   LEGAL DICTIONARY   testimonials   STATUTE OF LIMITATIONS  
 
Areas of Practice
Contact Us
 

Zometa

Zometa, or zoledronate, is a bisphosphonate drug marketed by Novartis taken intravenously and used to prevent osteoporosis and skeletal fractures in patients with multiple myeloma and other cancers. Multiple myeloma patients taking Zometa have been shown to have a high incidence of osteonecrosis of the jaw. Osteonecrosis, or "bone death," of the jaw is a condition in which there is pain, swelling, and bone damage around the tooth sockets. Loss of bone can lead to loose teeth, bone spurs, and other problems. Most cases of osteonecrosis of the jaw occur following dental procedures, and are often complicated by infection.

<< back



The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.

 
Copyright 2008 | Home | Contact 404-526-8866